{"id":"https://openalex.org/W32626419","doi":null,"title":"Compliance and persistence with concomitant statin and oral antihyperglycemic therapy.","display_name":"Compliance and persistence with concomitant statin and oral antihyperglycemic therapy.","alternate_titles":[],"publication_year":2011,"publication_date":"2011-11-01","ids":{"openalex":"https://openalex.org/W32626419","mag":"32626419","pmid":"https://pubmed.ncbi.nlm.nih.gov/22084894"},"language":"en","primary_location":{"id":"pmid:22084894","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22084894","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W32626419"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024547407","display_name":"Qiaoyi Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Qiaoyi Zhang","raw_affiliation_strings":["Global Health Outcomes, Merck Sharp and Dohme Corp, Whitehouse Station, NJ 08889, USA. qiaoyi_zhang@merck.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health Outcomes, Merck Sharp and Dohme Corp, Whitehouse Station, NJ 08889, USA. qiaoyi_zhang@merck.com","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104037981","display_name":"Changgeng Zhao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Changgeng Zhao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024193480","display_name":"Michael J. Davies","orcid":"https://orcid.org/0000-0003-1526-0801","observed_orcids":["https://orcid.org/0000-0003-1526-0801"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael J Davies","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000959913","display_name":"Larry Radican","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Larry Radican","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110110990","display_name":"Thomas L. Seck","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas Seck","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.5111,"has_fulltext":false,"cited_by_count":28,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.86540979,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"17","issue":"11","first_page":"746","last_page":"752"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10793","display_name":"Diabetes Management and Education","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9470000267028809},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9160000085830688},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.984000027179718},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.7860000133514404},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.8240000009536743},{"id":"https://openalex.org/keywords/medication-possession-ratio","display_name":"medication possession ratio","score":0.8349999785423279},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.8889999985694885},{"id":"https://openalex.org/keywords/concomitant-therapy","display_name":"concomitant therapy","score":0.7900000214576721},{"id":"https://openalex.org/keywords/medication-dispensing","display_name":"medication dispensing","score":0.42100000381469727}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9600723385810852},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8575723171234131},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.7325965166091919},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.7111952900886536},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6598113179206848},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6536169648170471},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5597760677337646},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5335438847541809},{"id":"https://openalex.org/C2781009140","wikidata":"https://www.wikidata.org/wiki/Q7170389","display_name":"Persistence (discontinuity)","level":2,"score":0.5123649835586548},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4916542172431946},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.482740581035614},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4455222487449646},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4368979334831238},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.42706114053726196},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.07537618279457092},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C187320778","wikidata":"https://www.wikidata.org/wiki/Q1349130","display_name":"Geotechnical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016001","descriptor_name":"Confidence Intervals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:22084894","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22084894","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Journal Article"},{"id":"mag:32626419","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22084894","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2149887886"],"related_works":["https://openalex.org/W1952813944","https://openalex.org/W1602622919","https://openalex.org/W2118597037","https://openalex.org/W2186751705","https://openalex.org/W2011691081","https://openalex.org/W1525863247","https://openalex.org/W2001475834","https://openalex.org/W1837867596","https://openalex.org/W2799670590","https://openalex.org/W1566978789"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"compare":[2],"compliance":[3],"and":[4,8,40,46,88,105,131,167,188,239],"persistence":[5,111,240],"with":[6,14,36,179,207,241,252,260],"statin":[7,45,104,139,166,187,202,224,242],"oral":[9,47,106,141,170,191,208,226,247],"antihyperglycemic":[10,48,107,142,171,192,209,227,248],"therapies":[11,49],"in":[12,54,66,79,250],"patients":[13,178,251],"type":[15,37,253],"2":[16,38,89,254],"diabetes":[17,39,255],"who":[18,256],"received":[19],"concomitant":[20],"therapy.":[21,108],"STUDY":[22],"DESIGN:":[23],"Retrospective":[24],"cohort":[25],"study":[26],"using":[27],"a":[28,118,148,180,219],"large":[29],"US":[30],"commercial":[31],"claims":[32],"database.":[33],"METHODS:":[34],"Patients":[35,72],"dispensed":[41],"prescriptions":[42],"for":[43,82,156,165,169,186,190],"both":[44,261],"on":[50],"the":[51,67,80,110,123],"same":[52],"date":[53,57,60,125],"2006":[55],"(index":[56],"=":[58,70],"first":[59],"of":[61,126,136,138,177,201],"such":[62],"dispensing)":[63],"were":[64,73,257],"included":[65],"analysis":[68],"(N":[69],"52,414).":[71],"required":[74],"to":[75,86,199,222],"have":[76],"continuous":[77],"enrollment":[78],"database":[81],"1":[83],"year":[84],"prior":[85],"(baseline)":[87],"years":[90],"after":[91],"(follow-up)":[92],"index":[93],"date.":[94],"The":[95,134,160,175,196],"2-year":[96,161,181],"medication":[97],"possession":[98],"ratio":[99],"(MPR)":[100],"was":[101,115,144,163,184,203,218],"compared":[102,206],"between":[103,122],"For":[109],"analysis,":[112],"treatment":[113],"discontinuation":[114,137,200],"defined":[116],"by":[117,146],"gap":[119],">30":[120],"days":[121],"last":[124],"supply":[127],"from":[128],"previous":[129],"dispensing":[130],"subsequent":[132],"refill.":[133],"likelihood":[135],"versus":[140],"therapy":[143,172,193,210,228,243,249],"estimated":[145],"fitting":[147],"robust":[149],"Cox":[150],"proportional":[151],"hazards":[152],"regression":[153],"model,":[154],"adjusted":[155],"baseline":[157],"variables.":[158],"RESULTS:":[159],"MPR":[162,182],"70%":[164],"78%":[168],"(P":[173,194],"<.0001).":[174,195],"proportion":[176],">80%":[183],"52%":[185],"63%":[189],"median":[197],"time":[198],"significantly":[204,244],"shorter":[205],"(284":[211],"vs":[212],"495":[213],"days,":[214],"P":[215],"<.001).":[216],"There":[217],"greater":[220],"risk":[221],"discontinue":[223],"than":[225],"(adjusted":[229],"hazard":[230],"ratio:":[231],"1.47":[232],"[95%":[233],"confidence":[234],"interval":[235],"1.45-1.48]).":[236],"CONCLUSIONS:":[237],"Compliance":[238],"lagged":[245],"behind":[246],"treated":[258],"concomitantly":[259],"therapies.":[262]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W32626419","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":6}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
